
Orchestra BioMed Holdings, Inc.
NASDAQ:OBIO
2.65 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 | 2023 | 2022 | 2021 | 2020 | |
---|---|---|---|---|---|
Operating Activities: | |||||
Net Income
| -61.024 | -49.12 | -33.608 | -23.014 | -21.355 |
Depreciation & Amortization
| 0.308 | 0.287 | 0.222 | 0.181 | 0.137 |
Deferred Income Tax
| 0 | 0 | -3.635 | 0.288 | 0 |
Stock Based Compensation
| 10.615 | 7.625 | 3.413 | 0.302 | 0.221 |
Change In Working Capital
| -0.765 | -3.307 | -0.451 | 2.597 | -8.12 |
Accounts Receivables
| 0.022 | -0.003 | 0.025 | 0.047 | -0.079 |
Inventory
| -0.028 | 0.131 | -0.208 | 0.001 | -0.026 |
Accounts Payables
| 2.969 | 0.145 | 0.183 | 1.078 | -2.607 |
Other Working Capital
| -3.728 | -3.58 | -0.451 | 1.471 | -5.408 |
Other Non Cash Items
| 0.308 | -1.612 | 4.77 | 0.217 | 2.934 |
Operating Cash Flow
| -50.558 | -46.127 | -29.289 | -19.429 | -26.183 |
Investing Activities: | |||||
Investments In Property Plant And Equipment
| -0.289 | -0.078 | -0.591 | -0.274 | -0.539 |
Acquisitions Net
| 0 | 0 | -29.06 | -13.291 | -27.505 |
Purchases Of Investments
| -72.648 | -142.032 | -63.531 | -0.213 | -15.624 |
Sales Maturities Of Investments
| 86.628 | 152.797 | 92.591 | 13.504 | 43.129 |
Other Investing Activites
| -0.602 | 0 | -63.531 | 13.291 | 27.505 |
Investing Cash Flow
| 13.089 | 10.687 | -64.122 | 13.017 | 26.966 |
Financing Activities: | |||||
Debt Repayment
| 15 | -10.849 | 3.554 | -4 | 10 |
Common Stock Issued
| 15.035 | 0.254 | 109.83 | 0 | 162.285 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| -0.864 | 57.064 | -10.127 | 0.007 | 0 |
Financing Cash Flow
| 29.171 | 46.215 | 103.257 | -3.993 | 10 |
Other Information: | |||||
Effect Of Forex Changes On Cash
| 0 | 0 | 11.425 | 0 | 0 |
Net Change In Cash
| -8.298 | 10.775 | 18.03 | -10.405 | 10.783 |
Cash At End Of Period
| 22.261 | 30.559 | 19.784 | 9.938 | 20.343 |